Literature DB >> 19452312

Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma.

Jia Ruan1, John P Leonard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19452312      PMCID: PMC2819380          DOI: 10.1080/10428190902893835

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  11 in total

Review 1.  Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.

Authors:  Napoleone Ferrara; Kenneth J Hillan; Hans-Peter Gerber; William Novotny
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

2.  A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.

Authors:  Alison T Stopeck; Joseph M Unger; Lisa M Rimsza; William T Bellamy; Maria Iannone; Daniel O Persky; Michael Leblanc; Richard I Fisher; Thomas P Miller
Journal:  Leuk Lymphoma       Date:  2009-05

3.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.

Authors:  Jia Ruan; Elizabeth Hyjek; Pouneh Kermani; Paul J Christos; Andrea T Hooper; Morton Coleman; Barbara Hempstead; John P Leonard; Amy Chadburn; Shahin Rafii
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

6.  Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.

Authors:  Kristen N Ganjoo; Caroline S An; Michael J Robertson; Leo I Gordon; Joy A Sen; Jill Weisenbach; Shuli Li; Edie A Weller; Attilio Orazi; Sandra J Horning
Journal:  Leuk Lymphoma       Date:  2006-06

7.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.

Authors:  Alexandra Abramsson; Per Lindblom; Christer Betsholtz
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

9.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

10.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.

Authors:  David K Jin; Koji Shido; Hans-Georg Kopp; Isabelle Petit; Sergey V Shmelkov; Lauren M Young; Andrea T Hooper; Hideki Amano; Scott T Avecilla; Beate Heissig; Koichi Hattori; Fan Zhang; Daniel J Hicklin; Yan Wu; Zhenping Zhu; Ashley Dunn; Hassan Salari; Zena Werb; Neil R Hackett; Ronald G Crystal; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2006-04-30       Impact factor: 53.440

View more
  3 in total

1.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

Review 2.  New Insights into Diffuse Large B-Cell Lymphoma Pathobiology.

Authors:  Antonio Giovanni Solimando; Tiziana Annese; Roberto Tamma; Giuseppe Ingravallo; Eugenio Maiorano; Angelo Vacca; Giorgina Specchia; Domenico Ribatti
Journal:  Cancers (Basel)       Date:  2020-07-11       Impact factor: 6.639

3.  Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2-dependent glutaminolysis pathway.

Authors:  Peng Wei; Alex J Bott; Ahmad A Cluntun; Jeffrey T Morgan; Corey N Cunningham; John C Schell; Yeyun Ouyang; Scott B Ficarro; Jarrod A Marto; Nika N Danial; Ralph J DeBerardinis; Jared Rutter
Journal:  Sci Adv       Date:  2022-09-30       Impact factor: 14.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.